<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04350723</url>
  </required_header>
  <id_info>
    <org_study_id>2154</org_study_id>
    <nct_id>NCT04350723</nct_id>
  </id_info>
  <brief_title>Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 COVID-19 (COVI-PRONE)</brief_title>
  <acronym>COVI-PRONE</acronym>
  <official_title>Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 (COVI-PRONE): A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Joseph's Healthcare Hamilton</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>King Abdullah International Medical Research Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Joseph's Healthcare Hamilton</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the COVI-PRONE Trial is to determine if early awake prone positioning in COVID-19&#xD;
      patients with hypoxemic respiratory failure; irrespective of the mode of oxygen delivery;&#xD;
      reduces the need for invasive mechanical ventilation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 10, 2020</start_date>
  <completion_date type="Actual">July 17, 2021</completion_date>
  <primary_completion_date type="Actual">July 17, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A multicenter, parallel-group randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endotracheal intubation</measure>
    <time_frame>within 30 days of randomization</time_frame>
    <description>Medical procedure in which a tube is placed into the windpipe (trachea) through the mouth.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>60 days</time_frame>
    <description>Death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Invasive mechanical ventilation free days</measure>
    <time_frame>censored at 30 Days</time_frame>
    <description>Number of days not receiving mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-invasive ventilation free days</measure>
    <time_frame>censored 30 days</time_frame>
    <description>Number of days not receiving non-invasive mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days alive and outside ICU</measure>
    <time_frame>60 Days</time_frame>
    <description>Number of days alive and outside the ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days alive and outside of hospital</measure>
    <time_frame>60 days</time_frame>
    <description>Number of days alive and outside of hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications from proning,</measure>
    <time_frame>30 days</time_frame>
    <description>Includes any of the following: accidental removal of intravenous access, hypotension, pressure injuries, or other.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">400</enrollment>
  <condition>Corona Virus Infection</condition>
  <condition>Covid19</condition>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Intervention - Awake Proning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The oxygen mask or NIPPV or HFNC will be initiated at the treating team's discretion. The patient will be observed for 15 minutes to ensure that: SPO2 &gt; 90% and the patient is tolerating oxygen mask or NIPPV or HFNC treatment.&#xD;
Once the patient achieves the above parameters within 15 minutes of initiating oxygen therapy through any modality, the healthcare team will start awake proning.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control - Standard of Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The patient will receive usual care without proning at the discretion of the treating team.&#xD;
The oxygen mask or NIPPV or HFNC will be initiated, the choice of starting oxygen mask versus NIPPV versus HFNC will be up to the treating team, the patient will be observed for 15 minutes to ensure that: SPO2 &gt; 90% and the patient is tolerating NIPPV or HFNC treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Awake Proning</intervention_name>
    <description>The duration of proning will be a total of 8-10 hours with 1-2 hours break in supine position.</description>
    <arm_group_label>Intervention - Awake Proning</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adults ≥ 18 years of age.&#xD;
&#xD;
          2. Suspected or confirmed COVID-19. Defined as: a positive PCR for SARS CoV-2 or pending&#xD;
             PCR results for patients that are suspected to have COVID-19.&#xD;
&#xD;
          3. Hypoxemia on room air (SPO2&lt;90%), and oxygen requirement ≥ 0.4 FiO2 (i.e. ≥ 40%&#xD;
             oxygen).&#xD;
&#xD;
          4. Bilateral or unilateral chest infiltrates on x-ray as interpreted by the treating&#xD;
             team.&#xD;
&#xD;
          5. Admitted to the ICU or an acute care bed where hemodynamic and respiratory monitoring&#xD;
             is feasible.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Immediate need for intubation as determined by the treating team.&#xD;
&#xD;
          2. Decreased level of consciousness (Glasgow Coma Scale score &lt;10), or significant&#xD;
             cognitive impairment hat may interfere with compliance (delirium, dementia)&#xD;
&#xD;
          3. Contraindication to proning including, but not limited to any of the following:&#xD;
&#xD;
             Open chest or abdomen, abdominal surgery (i.e. laparotomy) within the 4 days, Unstable&#xD;
             spine, facial, cervical, femur, or pelvic fractures. Limited neck mobility or&#xD;
             inability to lie prone comfortably Skeletal deformities that interfere with proning.&#xD;
             Complete bowel obstruction. Active upper gastrointestinal bleeding. Patient is&#xD;
             unlikely/unable to prone, or to be compliant as indicated by the treating team.&#xD;
&#xD;
          4. Body mass index &gt; 40 kg/m2&#xD;
&#xD;
          5. Pregnancy - third trimester.&#xD;
&#xD;
          6. Patient/substitute decision maker or caring physician's refusal to enroll in the&#xD;
             study.&#xD;
&#xD;
          7. Patients with hemodynamic instability and moderate to high dose of vasopressors&#xD;
             (norepinephrine dose ≥ 0.15 mcg/kg/min)&#xD;
&#xD;
          8. Intubation is not within patient's goals of care&#xD;
&#xD;
          9. Patient received awake proning session for &gt; 1 day prior to randomization&#xD;
&#xD;
         10. Previous intubation within the same hospital admission&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Waleed Alhazzani</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Joseph's Healthcare Hamilton</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yaseen Arabi</last_name>
    <role>Principal Investigator</role>
    <affiliation>King Saud Bin Abdulaziz University for Health Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zainab Alduhailib</last_name>
    <role>Principal Investigator</role>
    <affiliation>King Faisal Specialist Hospital and Research Center, Jeddah</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas Health Sciences Centre</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univeristy of Calgary</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Healthcare Hamilton</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hamilton General Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Juravinski Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Catharine's General -</name>
      <address>
        <city>St. Catharines</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sinai Health System</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Health Network - Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Québec - Université Laval</name>
      <address>
        <city>Quebec</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Al-Amir Hospital</name>
      <address>
        <city>Kuwait</city>
        <country>Kuwait</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jaber Al Ahmed hospital</name>
      <address>
        <city>Kuwait</city>
        <country>Kuwait</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Fahad Hospital of the University</name>
      <address>
        <city>Khobar</city>
        <state>Eastern Province</state>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prince Mohammed bin Abdulaziz Hospital</name>
      <address>
        <city>Al Madīnah</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Abdulaziz Hospital - NGHA</name>
      <address>
        <city>AlAhsa</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Abdulaziz Medical City - Jeddah</name>
      <address>
        <city>Jeddah</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Abdulaziz Medical City</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King Faisal Specialist Hospital &amp; Research Center</name>
      <address>
        <city>Riyadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Kuwait</country>
    <country>Saudi Arabia</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.coviprone.com</url>
    <description>www.COVIPRONE.com</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>April 14, 2020</study_first_submitted>
  <study_first_submitted_qc>April 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2020</study_first_posted>
  <last_update_submitted>October 14, 2021</last_update_submitted>
  <last_update_submitted_qc>October 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Joseph's Healthcare Hamilton</investigator_affiliation>
    <investigator_full_name>Waleed Al-Hazzani</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Coronavirus Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

